Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
1676
DELISTED
Zogenix, Inc.
ZGNX
| $9.58M | ﹤0.01% |
354,705
+51,676
| +17% | +$1.43M |
|
|
CVGW
1677
DELISTED
Calavo Growers
CVGW
| $9.58M | ﹤0.01% |
152,265
+3,793
| +3% | +$227K |
|
|
AQUA
1678
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $9.58M | ﹤0.01% |
514,980
+55,114
| +12% | +$912K |
|
|
MAGN
1679
Magnera Corp
MAGN
$487M
| $9.58M | ﹤0.01% |
45,898
+18,897
| +70% | +$3.58M |
|
|
CBB
1680
DELISTED
Cincinnati Bell Inc.
CBB
| $9.58M | ﹤0.01% |
644,857
+236,350
| +58% | +$3.49M |
|
1681
MaxLinear
MXL
$6.18B
| $9.54M | ﹤0.01% |
444,605
+38,076
| +9% | +$657K |
|
1682
Alamo Group
ALG
$1.97B
| $9.49M | ﹤0.01% |
92,441
-3,782
| -4% | -$363K |
|
1683
APi Group
APG
$17.2B
| $9.48M | ﹤0.01% |
+1,170,594
| New | +$8.86M |
|
1684
CareDx
CDNA
$2.48B
| $9.47M | ﹤0.01% |
267,316
+25,542
| +11% | +$727K |
|
|
ADVM
1685
DELISTED
Adverum Biotechnologies
ADVM
| $9.45M | ﹤0.01% |
45,240
+6,724
| +17% | +$1.19M |
|
1686
Genworth Financial
GNW
$3.83B
| $9.44M | ﹤0.01% |
4,084,910
+7,978
| +0.2% | +$25.1K |
|
1687
Kulicke & Soffa
KLIC
$4.67B
| $9.44M | ﹤0.01% |
452,972
-37,553
| -8% | -$850K |
|
1688
TriMas Corp
TRS
$1.44B
| $9.43M | ﹤0.01% |
393,687
-14,119
| -3% | -$324K |
|
|
NBIS
1689
Nebius Group N.V.
NBIS
$55.9B
| $9.42M | ﹤0.01% |
188,261
-60,471
| -24% | -$2.42M |
|
|
BPFH
1690
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $9.41M | ﹤0.01% |
1,367,425
+194,323
| +17% | +$1.36M |
|
|
VISN
1691
Vistance Networks Inc
VISN
$2.68B
| $9.39M | ﹤0.01% |
1,127,582
+73,815
| +7% | +$729K |
|
|
ITCI
1692
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $9.38M | ﹤0.01% |
365,376
+26,090
| +8% | +$528K |
|
|
TBI
1693
Trueblue
TBI
$231M
| $9.37M | ﹤0.01% |
613,643
-61,580
| -9% | -$915K |
|
1694
Virtus Investment Partners
VRTS
$1.1B
| $9.35M | ﹤0.01% |
80,414
+30,895
| +62% | +$2.89M |
|
1695
Nelnet
NNI
$4.95B
| $9.33M | ﹤0.01% |
195,419
-9,998
| -5% | -$468K |
|
1696
Wabash National
WNC
$505M
| $9.32M | ﹤0.01% |
877,536
-71,391
| -8% | -$629K |
|
1697
Opko Health
OPK
$978M
| $9.3M | ﹤0.01% |
2,727,408
+214,671
| +9% | +$481K |
|
1698
AAR Corp
AIR
$5.63B
| $9.28M | ﹤0.01% |
448,712
-12,627
| -3% | -$244K |
|
1699
G-III Apparel Group
GIII
$1.53B
| $9.26M | ﹤0.01% |
696,489
+63,378
| +10% | +$700K |
|
|
LMNX
1700
DELISTED
Luminex Corp
LMNX
| $9.24M | ﹤0.01% |
283,934
+20,711
| +8% | +$655K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.